Sponsors (28)
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Introduced May 9, 2025 by Judy Chu · Last progress May 9, 2025
Directs the Department of Health and Human Services to develop and carry out a national, culturally and linguistically tailored outreach and education strategy to reduce behavioral health stigma and increase service use among Asian American, Native Hawaiian, and Pacific Islander (AANHPI) communities. It also requires two systematic reviews—one focused on behavioral health among AANHPI youth and one on the AANHPI behavioral health workforce—and public reports with disaggregated data and recommendations. Requires interagency coordination (NIH, CDC, Office of Minority Health, HRSA, Department of Labor), consultation with AANHPI-serving organizations, and consumer engagement; mandates annual and one-time reports to Congress and public release of findings; and authorizes modest funding: $3,000,000 per year for FY2026–2030 for the outreach strategy and $1,500,000 each (FY2026) for the two systematic reviews.
The bill improves AANHPI-targeted behavioral health outreach, data disaggregation, and workforce planning—especially for youth—but does so with modest federal funding, added administrative burdens, and advisory studies that may limit immediate, scalable treatment gains and raise privacy and resource trade-offs.
AANHPI individuals (including immigrants) will gain greater access to culturally and linguistically appropriate behavioral health information and services, improving care-seeking and outcomes.
AANHPI youth (ages 10–24) will receive better-targeted behavioral health review and recommendations intended to reduce suicide, overdoses, and untreated mental illness.
Policymakers, researchers, and agencies will have improved, disaggregated AANHPI data (by race/ethnicity, age, sex, gender identity, sexual orientation, region, disability) to better identify subgroup needs and design targeted programs.
Taxpayers will bear additional federal costs (authorized ~$3M/year for outreach plus ~$1.5M and ~$1.5M allocations for reviews), requiring budget trade-offs or added spending.
Authorized funding levels are modest (relatively small annual and one‑year allocations), which may limit the scale, reach, and sustained impact of outreach, research, and workforce efforts.
Increasing outreach and awareness without guaranteed new funding for treatment could raise demand for services that local systems lack capacity to meet, delaying benefits for communities.